ArticleFrontiers in aging neuroscience2025
Machine learning models for the prediction of levodopa response to tremor in Parkinson's disease.
Article in Frontiers in aging neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To develop and validate machine learning models to predict levodopa responsiveness of tremor in Parkinson's disease (PD) patients. Methods: A total of 197 PD tremor patients underwent Levodopa Challenge Tests and were classified as having levodopa-responsive or levodopa-resistant tremor. Clinical and electromyogram (EMG) tremor analysis variables were recorded. The dataset was randomly divided into a training set (80%) and a test set (20%). To distinguish between the two groups, Support vector machine (SVM), random forest (RF), and logistic regression (LR) models were developed using training data. The optimal model was validated on test data. Calibration and decision curve analyses assessed model reliability and clinical utility. Results: Among 197 patients, 95 had levodopa-responsive tremor, and 102 had levodopa-resistant tremor. The SVM model showed the best performance, achieving an accuracy of 81.5% in five-fold cross-validation, with a Kappa score of 0.624, sensitivity of 84.3%, specificity of 77.9%, and an area under the curve (AUC) of 0.850. Performance remained consistent on test data, with 82.5% accuracy, 0.653 Kappa, 93.8% sensitivity, 75% specificity, and 0.896 AUC. The best model incorporated 6 predictors: resting tremor score, rigidity/tremor ratio, postural and kinetic tremor score, disease duration, the Movement Disorder Society's Unified Parkinson's Disease Rating Scale III (MDS-UPDRS III) /disease duration, and supine diastolic blood pressure (DBP). Conclusion: The SVM model, incorporating six key indicators, holds significant potential for predicting levodopa responsiveness in PD tremor, offering a valuable tool for the precise treatment of tremor in PD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.